Fragment-Based Development of HCV Protease Inhibitors for the Treatment of Hepatitis C

Publisher： Bentham Science Publishers

E-ISSN： 1875-6697|8|1|55-61

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.8, Iss.1, 2012-03, pp. : 55-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection

By Sheldon Julie   Barreiro Pablo   Vincent Vincent  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 8, 2007-08 ,pp. : 1171-1181

Informa Healthcare

Access to resources Recommend Favorite

Advances in the Development of Macrocyclic Inhibitors of Hepatitis C Virus NS3-4A Protease

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1403-1422

Bentham Science Publishers

Access to resources Recommend Favorite

The Second-generation of Highly Potent Hepatitis C Virus (HCV) NS3/4A Protease Inhibitors: Evolutionary Design Based on Tailor-made Amino Acids, Synthesis and Major Features of Bio-activity

By  

Current Pharmaceutical Design, Vol. 23, Iss. 30, 2017-11 ,pp. : 4493-4554

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Novel HCV NS3-4A Protease Inhibitors

By Hui Chang-Ye   Xie Xiao-Bing   Cao Hong   Huang Sheng-He  

Anti-Infective Agents, Vol. 11, Iss. 2, 2013-07 ,pp. : 125-135

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Novel HCV NS3-4A Protease Inhibitors

By  

Anti-Infective Agents, Vol. 11, Iss. 2, 2013-07 ,pp. : 125-135

Bentham Science Publishers

Access to resources Recommend Favorite